Becton, Dickinson and Company BDX, popularly known as BD, recently announced the global commercial launch of BD Research ...

FRANKLIN LAKES, N.J., Aug. 9, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a collaboration agreement with Labcorp ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced a collaboration with Biosero, a developer of laboratory automation solutions, to enable and facilitate robotic arm ...

FRANKLIN LAKES, N.J., Sept. 27, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today launched BD® Research Cloud, a cloud-based ...

FRANKLIN LAKES, N.J. and SAN DIEGO, Jan. 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, and Biosero, a developer of laboratory ...

BD FACSDiscover™ A8 Cell Analyzer to Enable Investigation of 30+ Cellular Characteristics to Capture Key Biological Insights and Support Planned 1,000-Person Immune Profiling Study FRANKLIN LAKES, N.J ...

FRANKLIN LAKES, N.J. & ASHLAND, Ore.--(BUSINESS WIRE)--FlowJo, LLC, the provider of the market-leading third-party software for single cell analysis, and BD Life Sciences – Biosciences, a segment of ...

BD is pairing up with Labcorp to develop a new line of companion diagnostics for cancer treatments and therapies for other diseases, analyzing patients’ cells using flow cytometry technology to match ...

Flow cytometry is a single-cell analytical technique that uses fluorophore-labeled cell structures or biomarkers to differentiate between cell populations. Through this method, researchers detect the ...